Physician profile
Candice C Fix
NPI 1528253853
$4,645.25
in general payments reported to CMS, 2019-2025
12 companies · $667 in 2025
The $667 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,902 · 2020: $259 · 2021: $369 · 2022: $519 · 2023: $366 · 2024: $564 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Entertainment: $24.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.31 |
| Entertainment | $24.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,756.43 | 2019-2025 | Precision7, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $246.15 | 2023-2025 | Infuse |
| Tarsus Pharmaceuticals, INC. | $180.70 | 2024 | Xdemvy |
| Optos, INC. | $141.45 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $78.05 | 2022 | |
| Coopervision INC. | $75.74 | 2021-2024 | Misight Contact Lens |
| Rxsight INC | $63.40 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Sun Pharmaceutical Industries INC. | $24.20 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.88 | 2020 | |
| Sight Sciences, INC. | $22.31 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candice Fix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.